Straight From the Cutter's Mouth

    Dr. Charles Wykoff of Retinal Consultants of Houston joins Jay to discuss the recently presented 2-year results of Regeneron's PANORAMA study of anti-VEGF for moderately severe and severe nonproliferative diabetic retinopathy.

    Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Alimera, Regeneron and Oxurion. Dr. Wykoff's relevant disclosures include consultant/speaker/research funding from Allergan, Genentech, Novartis and Regeneron, and consultant/research funding from Bayer and Roche.